Your Search Results

Mitral valve-in-valve, valve-in-ring, valve replacement: procedure challenges

20 May 2026 – From EuroPCR 2026

This session addresses procedural challenges in mitral valve interventions, including valve-in-valve, valve-in-ring, and valve replacement techniques. It covers lifetime management of patients with atrial fixated transcatheter mitral valve replacement (TMVR), approaches to recurrent mitral regurgitation, complex valve-in-valve cases, and hybrid strategies for valve-in-ring implantation, highlighting innovative...

Intracoronary imaging guidance in challenging PCI scenarios

20 May 2026 – From EuroPCR 2026

This session highlights the critical role of intracoronary imaging, particularly IVUS, in guiding complex percutaneous coronary interventions. It presents techniques such as IVUS-guided puncture of neo-ostia, stent implantation for ostial lesions, and innovative procedural methods like the Heart POTTER technique, underscoring the importance of precise imaging...

Beyond first implant: valve-in-valve, redo and leaflet modification

20 May 2026 – From EuroPCR 2026

This session explores advanced transcatheter aortic valve therapies beyond the first implant, focusing on valve-in-valve, redo procedures, and leaflet modification techniques. Topics include bioprosthetic valve fracture, long-term outcomes from the DURA-ViV registry, simplified workflows for leaflet modification in redo-TAVI, and intravascular ultrasound evaluation of valve expansion...

TAVI complications: the nurses and allied professionals' perspective

20 May 2026 – From EuroPCR 2026

This session highlights the critical role nurses and allied professionals (NAPs) play during TAVI complications. Through detailed clinical cases, it emphasizes their contributions in managing adverse events and explores the significance of structured debriefing to enhance team performance and patient outcomes.

TAVI procedural complications - Part 6: paravalvular leak, basilica and more

20 May 2026 – From EuroPCR 2026

Delve into complex TAVI procedural complications including paravalvular leak and challenges such as BASILICA technique failures, aortic dissection, valve infolding, and valve dislocation. This session presents real-world cases illustrating troubleshooting strategies and innovative interventions like TAVI-in-TAVI procedures to address these critical scenarios.

New insights in coronary atherosclerosis using intracoronary imaging

21 May 2026 – From EuroPCR 2026

This session provides new insights into coronary atherosclerosis through intracoronary imaging studies. It investigates the relationship between Lp(a) levels and high-risk plaques, characteristics of vulnerable plaques and thrombus in ACS, non-culprit lesion events, lipid core burden in STEMI, and the prognostic value of AI-derived lipid-to-cap ratios,...

Intracoronary imaging insights in ACS

20 May 2026 – From EuroPCR 2026

Discover how intracoronary imaging advances understanding and management of acute coronary syndromes (ACS). This session explores high-definition intravascular ultrasound for PCI guidance, novel predictive metrics, and the impact of emerging factors like microplastics on plaque instability, alongside pathophysiological insights into layered plaques and coronary ectasia in...

Intracoronary imaging evaluation of stent implantation

20 May 2026 – From EuroPCR 2026

Focusing on intracoronary imaging evaluation of stent implantation, this session presents serial OCT data on plaque characteristics and neoatherosclerosis post-STEMI, the clinical impact of stent malapposition in ACS, long-term apposition dynamics, factors influencing stent expansion in calcified lesions by NIRS-IVUS, and OCT insights into coronary artery...

RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

05 Sep 2023

Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.

Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...

Author

Alessandro Sticchi

RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

Evidence base: current data on TAVI durability and long-term outcomes

18 Jun 2026

This article reviews the current evidence on TAVI durability, focusing on long-term outcomes, device-specific considerations, and the implications for lifetime management strategies.

Author

Tanja Rudolph

Author

Georges El Hachem

Evidence base: current data on durability

SMT’s Supraflex Cruz shows consistent and robust clinical outcomes across key global studies presented at TCT 2025

29 Oct 2025

SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk

07 Nov 2021

Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...